使用混合摆形和口腔间的微型支杆支的骨脱稳机制的总治疗时间的比较:一项回顾性研究
Berrak Çakmak1, Selin Kale Varlık2, Tuba Tortop2
1Faculty of Dentistry, Department of Orthodontics, Gazi University, Ankara, Turkey. berrak@gazi.edu.tr.
BMC oral health
|August 21, 2025
概括
这项研究没有发现使用混合或迷你螺旋支的等级II缺陷治疗的总治疗时间有显著差异. 这两种方法都有效地纠正了缺陷,提供了可比的治疗时间.
科学领域:
- 牙整形
- 牙科机械
- 头骨和面部整形
背景情况:
- 第二类缺口是一种常见的牙科问题,需要有效的牙脱稳策略.
- 在正牙治疗中使用小型螺旋支器和混合装置来移动牙.
研究的目的:
- 为了比较使用混合摆形治疗的II类缺陷的总治疗时间与口腔间根间小螺杆支的位脱.
- 评价两种机制之间的摩尔脱时间和最终治疗结果的差异.
主要方法:
- 在80名II类缺陷患者中进行了回顾性队列研究.
- 患者被分为两组:混合 (P组) 和迷你机组支持的脱稳 (B组).
- 分析了治疗的持续时间,毛脱稳定时间和脑表变化.
主要成果:
- 这两组都实现了统计学上显著的牙不稳定,远端倾斜和下切口突出.
- 在治疗总持续时间 (大约24. 7个月) 或稳定持续时间 (大约7个月) 之间没有发现显著差异.
- 在这两组中,同行评价 (PAR) 评分也同样下降.
结论:
- 在口腔或口腔部位的小型支器之间做出选择不会影响II类缺陷的整体正牙治疗时间.
- 混合摆形和小螺旋支的移均在治疗II类缺陷时有效,治疗时间相似.
相关概念视频
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
145
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
145
Pharmacokinetic–Pharmacodynamic Relationship: Problems
129
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
129


